Casz1 is required for cardiomyocyte G1-to-S phase progression during mammalian cardiac development

Kerry M Dorr1, Nirav M Amin1, Lauren M Kuchenbrod1

  • 1University of North Carolina McAllister Heart Institute, UNC-Chapel Hill, Chapel Hill, NC 27599-3280, USA Department of Genetics, UNC-Chapel Hill, Chapel Hill, NC 27599-3280, USA.

Development (Cambridge, England)
|May 9, 2015
PubMed

Insights

The cardiac para-zinc-finger protein CASZ1 is crucial for cardiomyocyte proliferation and cell cycle progression. Loss of CASZ1 in mice reduces cardiomyocyte number and impairs DNA synthesis during heart development.

Area of Science:

  • Cardiovascular Biology
  • Molecular Biology
  • Developmental Biology

Background:

  • Organ growth relies on cell cycle progression, particularly cardiomyocyte proliferation, regulated by external signals.
  • Limited transcription factors are known to control cardiomyocyte entry into S phase.

Purpose of the Study:

  • To investigate the role of the cardiac para-zinc-finger protein CASZ1 in cardiomyocyte cell cycle progression.
  • To determine if CASZ1 is essential for cardiomyocyte proliferation in the developing heart.

Main Methods:

  • Generated genetically modified mice with inducible Casz1 alleles and cardiac conditional null mutations.
  • Utilized genetic fate mapping to trace CASZ1-expressing cells.
  • Analyzed cardiomyocyte proliferation, cell number, DNA synthesis, and cell cycle markers.

Main Results:

  • CASZ1 is expressed in murine cardiomyocytes and its expressing cells contribute to both first and second heart fields.
  • Loss of Casz1 significantly reduces cardiomyocyte proliferation and cell number.
  • Casz1 deficiency leads to prolonged/arrested S phase, decreased DNA synthesis, increased phospho-RB, and reduced mitotic index.

Conclusions:

  • CASZ1 is essential for mammalian cardiomyocyte cell cycle progression.
  • CASZ1 plays a critical role in regulating cardiomyocyte proliferation in both heart fields during development.